Avidity Partners Management LP
Source: SEC Form 13F · as of Mar 2026Avidity Partners Management LP holds 22 biotech & pharma companies tracked by BioSniper, totaling $690.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$690.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Dianthus Therapeutics, Inc. /DE/ (DNTH)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | 4,208,368 | $361.3M |
| ORKAOruka Therapeutics, Inc. | 1,520,848 | $89.3M |
| JBIOJade Biosciences, Inc. | 2,801,416 | $53.9M |
| CATXPerspective Therapeutics, Inc. | 12,099,998 | $48.8M |
| ELVNEnliven Therapeutics, Inc. | 800,000 | $32.2M |
| CNTXContext Therapeutics Inc. | 9,996,534 | $24.9M |
| TEVATeva Pharmaceutical Industries Limited | 650,100 | $20.6M |
| PVLAPALVELLA THERAPEUTICS, INC. | 140,000 | $17.7M |
| IMUXIMMUNIC, INC. | 7,369,352 | $13.9M |
| TENXTENAX THERAPEUTICS, INC. | 481,868 | $6.9M |
| GILDGILEAD SCIENCES, INC. | 40,000 | $5.4M |
| GPCRStructure Therapeutics Inc. | 78,000 | $3.4M |
| GMABGenmab A/S | 100,000 | $2.7M |
| NTLAIntellia Therapeutics, Inc. | 150,000 | $2.0M |
| MLTXMoonLake Immunotherapeutics | 100,000 | $1.8M |
| RVMDREVOLUTION MEDICINES, INC. | 15,000 | $1.5M |
| ABVXAbivax SA | 10,000 | $1.1M |
| ABUSArbutus Biopharma Corp | 250,000 | $1.1M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 87,706 | $761K |
| BBIOBridgeBio Pharma, Inc. | 10,000 | $711K |
| ACADACADIA PHARMACEUTICALS INC | 25,934 | $580K |
| SVRASavara Inc | 50,000 | $262K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.